Respiratory News and Research

RSS

Monoclonal antibody protects mice from lethal influenza A doses

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

8 May 2025

Air pollution reshapes children’s nasal microbiome and reduces diversity in winter

A new study from Milan reveals that short-term exposure to air pollutants like black carbon and VOCs significantly alters the nasal microbiota of school-aged children. These changes vary by season, with winter exposure reducing microbial diversity and favoring potentially pathogenic bacteria.

7 May 2025

Progesterone-only contraceptive pill linked to increased asthma attacks in some women

A major study of around 260,000 women shows that taking the progesterone-only contraceptive pill can increase asthma attacks in some women.

7 May 2025

New AI approach speeds up antiviral discovery for human enterovirus 71

Artificial intelligence algorithms have now been combined with traditional laboratory methods to uncover promising drug leads against human enterovirus 71 (EV71), the pathogen behind most cases of hand, foot and mouth disease.

6 May 2025

New tool uses eight health metrics to track biological aging

A novel health-assessment tool uses eight metrics derived from a person's physical exam and routine lab tests to characterize biological age.

6 May 2025

Wearable X-ray technology makes respiratory scans more comfortable for young children

Light conversion technology developed by University of Queensland researchers will be used for wearable X-ray devices that make respiratory scans more comfortable for young children.

6 May 2025

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron. The models demonstrated faster, cheaper, and more adaptable therapeutic development compared to traditional methods.

5 May 2025

UVA findings hold promise for developing targeted treatments for Long COVID lung complications

Groundbreaking research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of COVID-19 survivors, particularly those struggling with persistent breathing issues.

5 May 2025

Asthma-related emergency visits increase during wildfire smoke events in Ontario

New research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241506 found an increase in asthma-related emergency department (ED) visits across Ontario following heavy smoke in early June 2023.

5 May 2025

Trump team’s $500 million bet on old vaccine technology puzzles scientists

The Trump administration's unprecedented $500 million grant for a broadly protective flu shot has confounded vaccine and pandemic preparedness experts, who said the project was in early stages, relied on old technology, and was just one of more than 200 such efforts.

5 May 2025

New albumin-based vaccine shows promise for mucosal immunity

Vaccines save millions of lives every year, but there is still an urgent need for more efficient vaccines. Strategies to combat serious outbreaks of viral infections are particularly important.

2 May 2025

New studies link increased heart disease risk to tobacco and cannabis use

New clinical results from multiple studies show coronary heart disease death associated with tobacco use is anticipated to rise up to 40% in the next five years and people with cannabis use disorder are 50% more likely to experience cardiogenic shock, acute myocardial infarction, and arrhythmias.

2 May 2025

COVID-19 leaves longer-lasting symptoms than flu or pneumonia, study finds

A large U.S. cohort study found that post-acute symptoms after COVID-19 vary by initial disease severity, age, sex, and comorbidities. Compared to influenza and pneumonia, long COVID presented with distinct symptom patterns and longer-lasting effects.

1 May 2025

HHS and NIH announce the development of next-generation, universal vaccine platform

Colorized transmission electron micrograph of influenza A/H1N1 virus particles. The U.S. Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) today announced the development of the next-generation, universal vaccine platform, Generation Gold Standard, using a beta-propiolactone (BPL)-inactivated, whole-virus platform.

1 May 2025

Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy

A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy (DMD), a severe condition that leads to muscle weakness and premature death.

30 Apr 2025

Researchers identify blood biomarkers linked to Long COVID symptoms

Researchers at Karolinska Institutet have identified biomarkers in the blood associated with symptoms of long COVID, particularly severe respiratory disorders.

30 Apr 2025

New antiviral compounds show broad protection against COVID-19 variants

Novel Mpro inhibitors exhibit broad activity against SARS-CoV-2 and other coronaviruses.

30 Apr 2025

Machine learning uncovers promising drug leads against human enterovirus 71

Artificial intelligence algorithms have now been combined with traditional laboratory methods to uncover promising drug leads against human enterovirus 71 (EV71), the pathogen behind most cases of hand, foot and mouth disease.

29 Apr 2025

Measles makes a deadly comeback in Europe as vaccine gaps widen

In 2024, measles cases in Europe soared to the highest levels in decades, with over 35,000 reported cases, 87% from Romania alone. Most affected were unvaccinated children, revealing critical immunity gaps and suboptimal vaccination coverage across the EU/EEA.

29 Apr 2025

Perceived stress linked to worsened symptoms in COPD patients

Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study.

29 Apr 2025